- Home
- PROK vs FCEL Comparison
PROK vs FCEL Comparison
Compare PROK & FCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PROK
- FCEL
- Stock Information
- Founded
- PROK 2015
- FCEL 1969
- Country
- PROK United States
- FCEL United States
- Employees
- PROK N/A
- FCEL N/A
- Industry
- PROK Biotechnology: Biological Products (No Diagnostic Substances)
- FCEL Industrial Machinery/Components
- Sector
- PROK Health Care
- FCEL Energy
- Exchange
- PROK Nasdaq
- FCEL Nasdaq
- Market Cap
- PROK 211.1M
- FCEL 201.3M
- IPO Year
- PROK N/A
- FCEL 1992
- Fundamental
- Price
- PROK $1.62
- FCEL $7.58
- Analyst Decision
- PROK Buy
- FCEL Hold
- Analyst Count
- PROK 5
- FCEL 6
- Target Price
- PROK $4.50
- FCEL $22.78
- AVG Volume (30 Days)
- PROK 409.2K
- FCEL 1.1M
- Earning Date
- PROK 03-21-2025
- FCEL 03-06-2025
- Dividend Yield
- PROK N/A
- FCEL N/A
- EPS Growth
- PROK N/A
- FCEL N/A
- EPS
- PROK N/A
- FCEL N/A
- Revenue
- PROK N/A
- FCEL $112,132,000.00
- Revenue This Year
- PROK N/A
- FCEL $64.70
- Revenue Next Year
- PROK N/A
- FCEL $3.10
- P/E Ratio
- PROK N/A
- FCEL N/A
- Revenue Growth
- PROK N/A
- FCEL N/A
- 52 Week Low
- PROK $1.18
- FCEL $5.45
- 52 Week High
- PROK $4.44
- FCEL $45.60
- Technical
- Relative Strength Index (RSI)
- PROK 45.03
- FCEL 37.40
- Support Level
- PROK $1.57
- FCEL $7.10
- Resistance Level
- PROK $1.77
- FCEL $8.07
- Average True Range (ATR)
- PROK 0.13
- FCEL 0.57
- MACD
- PROK -0.00
- FCEL -0.13
- Stochastic Oscillator
- PROK 31.25
- FCEL 17.20
About PROK ProKidney Corp.
ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease. The company's pipeline consists of development program for severe diabetic kidney disease.
About FCEL FuelCell Energy Inc.
FuelCell Energy Inc is a fuel-cell power company. FuelCell designs manufactures, sells, installs, operates, and services fuel cell products and electrolysis platforms that decarbonize power and produce hydrogen. It serves various industries such as Industrial, Wastewater treatment, Commercial and Hospitality, Data centers and Communications, Education and Healthcare, and others. Geographically, the company generates a majority of its revenue from the United States followed by South Korea.